The European AIDS Treatment Group and 30 other Civil Society organisations have reached out to the European Commission today to ask for a strong EU engagement to tackle the issue of medicines shortages:
As representatives of organisations of patients, consumers, healthcare professionals and public health advocates, we consider that the mandate of the European Commission to assist in alleviating medicines shortage problems includes, but also goes beyond, facilitating best practice-sharing. Given that medicines shortages are impacting patient care in all Member States, a strong EU commitment under the leadership of the European Commission is needed to contain the problems and ensure remedy, as acknowledged by the European Commission itself in its contribution to the informal EU27 leaders’ meeting in Sibiu (Romania) on 9 May 2019. Such engagement should be carried out in coherent addition to the efforts by the joint task force of the Heads of Medicines Agencies and the European Medicines Agency on the availability of authorised medicines for human and veterinary use.
The undersigned associations request the European Commission to start an investigation into the factors leading to medicines shortages to provide clear and transparent information on the root causes of these problems, including on responsible entities and affected population groups, to healthcare professionals, patients and the general public. Further evidence on EU’s medicines shortage crisis should also inform the planning of the activities of the Directorate General for Health and Food Safety during the next legislative period.
Read the letter here
The letter was coordinated by France Assos Santé